Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biotène Oralbalance is a topical oral moisturizing gel developed and marketed by Haleon (formerly GSK Consumer Healthcare) for the relief of xerostomia (dry mouth). The formulation is designed to mimic the natural protective environment of the mouth by incorporating a multi-enzyme system consisting of lysozyme, lactoferrin, lactoperoxidase, and glucose oxidase. These components, along with moisturizing agents like xylitol and aloe vera, help lubricate oral tissues and provide up to four hours of symptom relief. As a non-prescription, alcohol-free, and sugar-free product, it is generally classified as a medical device or consumer health product rather than a traditional pharmaceutical drug. It has been evaluated in clinical settings comparing its efficacy to other salivary substitutes in patients with oral and maxillofacial conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Biotène Oralbalance.